Robert Walder
Direttore/Membro del Consiglio presso The Country Club of Rancho Bernardo
Posizioni attive di Robert Walder
Società | Posizione | Inizio | Fine |
---|---|---|---|
Samaritan Group | Corporate Officer/Principal | 20/05/2010 | - |
The Country Club of Rancho Bernardo | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Robert Walder
Precedenti posizioni note di Robert Walder
Società | Posizione | Inizio | Fine |
---|---|---|---|
STAR EQUITY HOLDINGS, INC. | Corporate Officer/Principal | 01/09/2006 | 01/09/2006 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/12/2000 | 01/12/2000 |
TEARLAB CORPORATION | Corporate Officer/Principal | 01/01/2008 | - |
OcuSense, Inc.
OcuSense, Inc. Medical SpecialtiesHealth Technology OcuSense, Inc. develops in-vitro diagnostics technologies. It engages in developing tests for other ocular surface diseases and measuring biomarkers for diagnosis and management of eye diseases. The company was founded by Eric Donsky and Benjamin D. Sullivan in 2003 and is headquartered in San Diego, CA. | Direttore operativo | 06/10/2008 | - |
Formazione di Robert Walder
University of Southern California | Doctorate Degree |
The California State University | Undergraduate Degree |
University of Phoenix | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Posizioni
Corporate Officer/Principal | 4 |
Undergraduate Degree | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
STAR EQUITY HOLDINGS, INC. | Health Technology |
Aziende private | 4 |
---|---|
TearLab Corporation, Inc.
TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Southlake, TX. | Health Technology |
OcuSense, Inc.
OcuSense, Inc. Medical SpecialtiesHealth Technology OcuSense, Inc. develops in-vitro diagnostics technologies. It engages in developing tests for other ocular surface diseases and measuring biomarkers for diagnosis and management of eye diseases. The company was founded by Eric Donsky and Benjamin D. Sullivan in 2003 and is headquartered in San Diego, CA. | Health Technology |
Samaritan Group | |
The Country Club of Rancho Bernardo |
- Borsa valori
- Insiders
- Robert Walder
- Esperienza